ChemicalBook > CAS DataBase List > LDE-225 Diphosphate

LDE-225 Diphosphate

Product Name
LDE-225 Diphosphate
CAS No.
1218778-77-8
Chemical Name
LDE-225 Diphosphate
Synonyms
NVP-LDE225;LDE225;LDE 225 phosphate;LDE 225 Diphosphate;LDE-225 Diphosphate;Sonidegib phosphate;LDE225 (Diphosphate);Erismodegib phosphate;Sonidegib diphosphate;NVP-LDE 225 Diphosphate;ErisModegib Diphosphate
CBNumber
CB42666648
Molecular Formula
C26H32F3N3O11P2
Formula Weight
681.4885116
MOL File
1218778-77-8.mol
More
Less

LDE-225 Diphosphate Property

storage temp. 
Store at -20°C
solubility 
≥27.85 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
form 
White solid.
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
16263
Product name
LDE225 (phosphate)
Purity
≥98%
Packaging
1mg
Price
$32
Updated
2024/03/01
Cayman Chemical
Product number
16263
Product name
LDE225 (phosphate)
Purity
≥98%
Packaging
5mg
Price
$116
Updated
2024/03/01
Cayman Chemical
Product number
16263
Product name
LDE225 (phosphate)
Purity
≥98%
Packaging
10mg
Price
$199
Updated
2024/03/01
Cayman Chemical
Product number
16263
Product name
LDE225 (phosphate)
Purity
≥98%
Packaging
25mg
Price
$456
Updated
2024/03/01
TRC
Product number
N925913
Product name
NVP-LDE225DiphosphateSalt
Packaging
10mg
Price
$165
Updated
2021/12/16
More
Less

LDE-225 Diphosphate Chemical Properties,Usage,Production

Description

Sonidegib phosphate (XXIX), an orally bioavailable, small molecule smoothened (SMO) receptor antagonist developed by Novartis, was approved in 2015 in Switzerland, the U.S., and the EU for the treatment of adult patients with advanced or locally advanced basal cell carcinoma (BCC). BCC is the most frequently diagnosed skin cancer, constituting 80% of all nonmelanoma skin cancers. While most BCCs can be treated through surgery or radiation therapy, some patients (<10%) have more advanced tumors for which surgery may be contraindicated or impractical; treatment options for these patients are limited. SMO, a G-protein coupled receptor-like protein (GPCR), is a key regulator in the hedgehog (Hh) pathway, which is activated in a number of tumors including BCC. In a multicenter clinical trial for sonidegib, an objective response rate of 43% was observed for patients with locally advanced BCC (dosing at 200 mg once daily), with sustained clinically meaningful responses based on an 18-month analysis. Sonidegib joins vismodegib as marketable treatments of BCC. Vismodegib, which was approved in 2012 as a first-in-class SMO receptor antagonist, represented the first Hedgehog signaling pathway targeting agent to gain FDA approval.

Uses

NVP-LDE225 Diphosphate Salt is a potent, selective, and orally bioavailable Smoothened (Hedgehog Signaling Pathway) antagonist.

Definition

ChEBI: A phosphate salt obtained by reaction sonidegib with two equivalent of phosphoric acid. Used for treatment of locally advanced basal cell carcinoma.

Synthesis

The synthesis was initiated with an SNAr reaction involving commercial 2-chloro- 5-nitropyridine (226) and cis-dimethylmorpholine (227) followed by subsequent nitro reduction via hydrogenation to provide amine 228. The crude amine was coupled directly to 3- bromo-2-methylbenzoic acid (229) in an amide bond-forming reaction to construct 230 in 77% yield over three steps. The resultant bromide was coupled to 4-(trifluoromethoxy)- phenylboronic acid (231) under Suzuki conditions to give rise to sonidegib as the freebase. Finally, treatment with 85% aqueous phosphoric acid in acetonitrile generated sonidegib phosphate (XXIX) in good yield.

in vitro

lde225 was found to selectively bind to the hedgehog (hh)-ligand cell surface receptor smo, which might result in the suppression of the hh signaling pathway and, therefore, the inhibition of tumor cells in which this pathway was abnormally activated [1].

in vivo

in the subcutaneous medulloblastoma allograft mouse model, lde225 demonstrated dose-related antitumor activity after 10 days of oral administration of a suspension. at a dose of 5 mg/kg/ day qd, lde225 inhibited tumor growth significantly, corresponding to a t/c value of 33%. when dosed at 10 and 20 mg/kg/day qd, lde225 afforded 51 and 83% regression, respectively [1].

IC 50

1.3 and 2.5 nm for mouse and human smo

References

[1] shifeng pan,xu wu,jiqing jiang et al. discovery of nvp-lde225, a potent and selective smoothened antagonist. acs med chem lett. 2010 jun 10; 1(3): 130–134.
[2] rodon j,tawbi ha,thomas al,stoller rg,turtschi cp,baselga j,sarantopoulos j,mahalingam d,shou y,moles ma,yang l,granvil c,hurh e,rose kl,amakye dd,dummer r,mita ac. a phase i, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor sonidegib (lde225) in patients with advanced solid tumors. clin cancer res.2014 apr 1;20(7):1900-9.

LDE-225 Diphosphate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

LDE-225 Diphosphate Suppliers

Beijing Jingzi Pharmaceutical Technology Co., Ltd.
Tel
15011485209
Email
17241816@qq.com
Country
China
ProdList
81
Advantage
58
Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
ZHIWE CHEMTECH CO LTD
Tel
021-20221225 13917446399
Fax
QQ:115820162
Email
sales@zhiwe.net
Country
China
ProdList
608
Advantage
61
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185 18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3466
Advantage
58
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Fax
051085625359
Email
sales@reading-chemicals.com
Country
China
ProdList
15178
Advantage
58
Suzhou yacoo science co.,Ltd
Tel
0512-87182056 18013166090
Fax
0512-87182056
Email
lingling.qi@yacoo.com.cn
Country
China
ProdList
7295
Advantage
60
AdooQ Bioscience CHINA
Tel
025-58849295 18951903616;
Fax
025-68650336
Email
info@adooq.cn
Country
China
ProdList
2990
Advantage
60
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Shanghai YuanQi Biotechnology Co., Ltd.
Tel
+86-2332782371 +86-18120098618
Email
sales@adobechem.com
Country
China
ProdList
1250
Advantage
50
Shanghaizehan biopharma technology co., Ltd.
Tel
021-61350663 13052117465
Fax
021-61350662
Email
sales@zehanbiopharma.com
Country
China
ProdList
1009
Advantage
55
SPIRO PHARMA
Tel
Fax
-
Email
eric_feng1954@126.com
Country
China
ProdList
9248
Advantage
55
Pharmacodia (Beijing) Co.,Ltd
Tel
+86-400-851-9921
Fax
+86-10-82826195
Email
sales@pharmacodia.com
Country
China
ProdList
2317
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9806
Advantage
58
Guangzhou QiYun Biotechnology Co., Ltd.
Tel
020-61288194 61288195
Fax
020-61288700
Email
505721671@qq.com
Country
China
ProdList
3866
Advantage
58
Lancrix Chemicals
Tel
86-21-50817262
Fax
86-21-57712035
Email
sales@lancrix.com
Country
China
ProdList
1502
Advantage
55
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8011
Advantage
62
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
7267
Advantage
58
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 4009686088
Email
3193328036@qq.com
Country
China
ProdList
29785
Advantage
68
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131957
Advantage
58
Lynnchem
Tel
86-(0)29-85992781 17792393971
Email
info@lynnchem.com
Country
China
ProdList
4587
Advantage
58
Shenzhen Regent Biochemical Technology Co., Ltd.
Tel
0755-0755-85201366 18938635012
Fax
0755-85201366
Email
sales@regentsciences.com
Country
China
ProdList
9355
Advantage
58
Twochem Co.Ltd.
Tel
021-58111628 15800915896
Fax
QQ 3285589261
Email
sales@twochem.com
Country
China
ProdList
1788
Advantage
58
Alchemist-pharm chemical Technology Co. Ltd.
Tel
0371-67991738 13783628208
Fax
QQ 412703949
Email
carl@alchemist-pharm.com
Country
China
ProdList
1872
Advantage
58
Angel Pharmatech, Ltd.
Tel
17317130613
Fax
QQ3358272972
Email
3358272972@qq.com
Country
China
ProdList
3251
Advantage
58
DC Chemicals
Tel
021-58447131 13564518121
Email
sales@dcchemicals.com
Country
China
ProdList
9409
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11217
Advantage
58
career henan chemical co
Tel
+86-0371-86658258 +8613203830695
Fax
0086-371-86658258
Email
factory@coreychem.com
Country
China
ProdList
29811
Advantage
58
Absin Bioscience Inc.
Tel
021-38015121 15000105423
Email
wulan@absin.cn
Country
China
ProdList
24731
Advantage
58
Shanghai Luofa Biochemical Technology Co., Ltd.
Tel
021-51111890 15317326293
Email
sales@molnova.com
Country
China
ProdList
4195
Advantage
58
Wuxi Helen Biotechnology Co., Ltd.,
Tel
0510-85629785 18013409632
Fax
0510-85625359
Email
sales@reading-chemicals.com
Country
China
ProdList
14081
Advantage
58
Shanghai Botuo Biotechnology Co., LTD
Tel
16621358918
Fax
QQ:402135374
Email
botuopharma888@163.com
Country
China
ProdList
9208
Advantage
58
MedBioPharmaceutical Technology Inc
Tel
021-69568360 18916172912
Email
order@med-bio.cn
Country
China
ProdList
8140
Advantage
58
Wuhan Topule
Tel
+86-02787215551 +86-19945035818
Fax
027-87215551
Email
2936752263@qq.com
Country
China
ProdList
7973
Advantage
58
Abmole Bioscience Inc.
Tel
021-50967598 02150967598
Email
sales@abmole.cn
Country
China
ProdList
4494
Advantage
58
Hubei Kele Fine Chemical Co., Ltd
Tel
027-59101668 19945030958
Fax
027-59101668
Email
2881924765@qq.com
Country
China
ProdList
8140
Advantage
58
Bide Pharmatech Ltd.
Tel
400-1647117 13681763483
Email
product02@bidepharm.com
Country
China
ProdList
62163
Advantage
58
InvivoChem
Tel
13549236410
Email
sales@invivochem.cn
Country
China
ProdList
6753
Advantage
58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.
Tel
+86-027-59232304 15387063101
Email
2881924050@qq.com
Country
China
ProdList
9951
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24647
Advantage
58
Shanghai Haozhu Pharmaceutical Technology Co. , Ltd.
Tel
18912729622
Email
66161984@qq.com
Country
China
ProdList
897
Advantage
58
Hangzhou Bingochem Co., Ltd.
Tel
0571-8512-5372
Email
sales@bingochem.com
Country
China
ProdList
21669
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
025-85560043 15850508050
Fax
025-85563444
Email
cindy.huang@synzest.com
Country
China
ProdList
12005
Advantage
58
Shanghai jerryxing Biomedical Technology Co., Ltd
Tel
17721492509
Email
643638326@qq.com
Country
China
ProdList
5345
Advantage
58
SuZhou GoodChemTech Co., Ltd
Tel
18136139868
Email
jinlun@goodchemtech.cn
Country
China
ProdList
221
Advantage
58
RD International Technology Co., Limited
Tel
18024082417
Email
market@ubiochem.com
Country
China
ProdList
9272
Advantage
58
Henan Fangding Technology Co., LTD
Tel
15670369782
Email
15670369782@163.com
Country
China
ProdList
10051
Advantage
58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd
Tel
17316404525
Email
209533805@qq.com
Country
China
ProdList
9762
Advantage
58
SHANGHAI KEAN TECHNOLOGY CO., LTD.
Tel
+8613817748580
Fax
021-50175322
Email
cooperation@kean-chem.com
Country
China
ProdList
40066
Advantage
58
Henan Fengda Chemical Co., Ltd
Tel
+86-371-86557731 +86-13613820652
Fax
86-0371-86557731
Email
info@fdachem.com
Country
China
ProdList
20287
Advantage
58
More
Less

View Lastest Price from LDE-225 Diphosphate manufacturers

Career Henan Chemical Co
Product
LDE-225 Diphosphate 1218778-77-8
Price
US $1.00/g
Min. Order
1g
Purity
99%
Supply Ability
200kg
Release date
2020-01-10

1218778-77-8, LDE-225 DiphosphateRelated Search:


  • NVP-LDE225;LDE225
  • NVP-LDE225;LDE225;LDE 225 DIPHOSPHATE;NVP-LDE 225 DIPHOSPHATE;ERISMODEGIB DIPHOSPHATE;LDE-225 DIPHOSPHATE
  • Erismodegib diphosphate (LDE225 diphosphate)
  • LDE225 Diphosphate, >=98%
  • Erismodegib Diphosphate, NVP-LDE225 (diphosphate salt)
  • Sonidegib (NVP-LDE225) Diphosphate
  • ErisModegib Diphosphate
  • LDE 225 Diphosphate
  • LDE225 (Diphosphate)
  • LDE-225 Diphosphate
  • NVP-LDE 225 Diphosphate
  • LDE 225 phosphate
  • rel-N-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide phosphate (1:2)
  • Sonidegib phosphate
  • Erismodegib phosphate
  • Sonidegib diphosphate
  • Sonidegib phosphate (NVP-LDE-225, Erismodegib, Odomzo)
  • N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide,phosphoric acid
  • NVP-LDE225 diphosphate,Inhibitor,Smoothened,Sonidegib diphosphate,Smo,inhibit
  • rel-N-(6-((2R,6S)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide bis(phosphate)
  • NVP-LDE225 DIPHOSPHATE SALT (ERISMODEGIB, SONIDEGIB)
  • rel-N-(6-((2R,6S)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide bis(phosphate)
  • 1218778-77-8
  • C26H32F3N3O11P2
  • C26H26F3N3O32H3PO4